[HIV lipodystrophy syndrome: a new challenge to the endocrinologist].
Valente
Orsine
O
Valente
Angélica M Martins
AM
D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced*; D006801:Humans
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors